Shanghai Rongtai Health Technology Corporation Limited
SSE:603579.SS
27.02 (CNY) • At close May 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,596.868 | 1,855.029 | 2,004.821 | 2,612.57 | 2,020.516 | 2,313.912 | 2,295.648 | 1,918.007 | 1,285.05 | 1,023.978 | 723.142 | 411.401 | 326.537 | 331.044 |
| Cost of Revenue
| 1,090.977 | 1,288.609 | 1,473.069 | 1,911.466 | 1,440.574 | 1,590.226 | 1,513.605 | 1,184.976 | 794.7 | 692.163 | 503.65 | 299.578 | 239.384 | 244.218 |
| Gross Profit
| 505.892 | 566.42 | 531.751 | 701.104 | 579.943 | 723.685 | 782.043 | 733.031 | 490.35 | 331.815 | 219.492 | 111.823 | 87.153 | 86.825 |
| Gross Profit Ratio
| 0.317 | 0.305 | 0.265 | 0.268 | 0.287 | 0.313 | 0.341 | 0.382 | 0.382 | 0.324 | 0.304 | 0.272 | 0.267 | 0.262 |
| Reseach & Development Expenses
| 80.104 | 80.176 | 88.659 | 119.207 | 100.121 | 122.602 | 108.757 | 101.132 | 60.463 | 47.199 | 38.669 | 21.968 | 18.862 | 0 |
| General & Administrative Expenses
| 25.716 | 19.716 | 17.269 | 21.227 | 14.878 | 3.461 | 27.167 | 28.634 | 12.338 | 8.3 | 12.331 | 5.666 | 35.617 | 37.417 |
| Selling & Marketing Expenses
| 130.558 | 204.444 | 209.633 | 255.31 | 188.976 | 266.266 | 283.484 | 263.388 | 174.576 | 106.979 | 78.291 | 50.524 | 46.991 | 28.404 |
| SG&A
| 156.274 | 224.16 | 226.902 | 276.537 | 203.854 | 269.727 | 310.651 | 292.022 | 186.915 | 115.28 | 90.622 | 56.19 | 82.608 | 65.821 |
| Other Expenses
| 59.113 | -31.82 | 45.117 | 41.056 | 32.511 | 37.642 | 49.477 | -6.796 | 10.332 | 5.581 | 1.697 | 3.831 | 5.046 | 1.978 |
| Operating Expenses
| 295.491 | 330.71 | 360.679 | 436.801 | 336.487 | 429.97 | 468.884 | 432.228 | 277.273 | 185.33 | 146.152 | 88.696 | 82.947 | 66.216 |
| Operating Income
| 210.4 | 235.955 | 186.537 | 265.225 | 200.362 | 326.914 | 280.687 | 257.518 | 232.92 | 160.603 | 69.343 | 25.611 | 1.818 | 19.598 |
| Operating Income Ratio
| 0.132 | 0.127 | 0.093 | 0.102 | 0.099 | 0.141 | 0.122 | 0.134 | 0.181 | 0.157 | 0.096 | 0.062 | 0.006 | 0.059 |
| Total Other Income Expenses Net
| -0.406 | -5.763 | -7.164 | -4.261 | -2.19 | 0.875 | 1.178 | 2.124 | 9.549 | 5.658 | 2.063 | 3.822 | 5.024 | 1.971 |
| Income Before Tax
| 209.994 | 230.192 | 179.373 | 260.964 | 198.172 | 327.788 | 281.865 | 259.641 | 242.536 | 166.261 | 71.406 | 29.434 | 6.842 | 21.57 |
| Income Before Tax Ratio
| 0.132 | 0.124 | 0.089 | 0.1 | 0.098 | 0.142 | 0.123 | 0.135 | 0.189 | 0.162 | 0.099 | 0.072 | 0.021 | 0.065 |
| Income Tax Expense
| 18.186 | 26.86 | 14.653 | 32.931 | 17.205 | 39.625 | 31.925 | 33.053 | 33.53 | 22.488 | 9.338 | 3.351 | -0.218 | 2.82 |
| Net Income
| 191.946 | 202.707 | 164.228 | 236.336 | 193.001 | 295.589 | 249.21 | 216.175 | 206.646 | 142.702 | 61.579 | 25.825 | 6.764 | 18.561 |
| Net Income Ratio
| 0.12 | 0.109 | 0.082 | 0.09 | 0.096 | 0.128 | 0.109 | 0.113 | 0.161 | 0.139 | 0.085 | 0.063 | 0.021 | 0.056 |
| EPS
| 1.11 | 1.16 | 1.21 | 1.75 | 1.42 | 2.13 | 1.78 | 1.58 | 1.97 | 1.36 | 0.6 | 0.26 | 0.14 | 0.37 |
| EPS Diluted
| 0.97 | 1.13 | 1.21 | 1.69 | 1.41 | 2.13 | 1.78 | 1.58 | 1.97 | 1.36 | 0.6 | 0.26 | 0.14 | 0.37 |
| EBITDA
| 272.91 | 326.088 | 281.303 | 357.212 | 252.157 | 411.791 | 383.206 | 316.769 | 274.704 | 197.182 | 81.633 | 34.604 | 7.515 | 24.502 |
| EBITDA Ratio
| 0.171 | 0.176 | 0.14 | 0.137 | 0.125 | 0.178 | 0.167 | 0.165 | 0.214 | 0.193 | 0.113 | 0.084 | 0.023 | 0.074 |